Home
Lynx1 Capital Management reported a 9.99% stake in C4 Therapeutics CCCC · 15,423,691 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 9.99%
- Last report
- 7.3% · filed 26/02/17
- Shares held
- 15,423,691 sh
- Class
- Common Stock, $0.0001 par value per share
- Stock
- C4 Therapeutics CCCC
- Holder
- Lynx1 Capital Management
- Event date
- 26/06/30
- Filed
- 26/08/14
9.99% stake · +2.7pp from the last report
- Stake
- 9.99%
- Last report
- 7.3%
- Since last report
- +2.7pp
C4 Therapeutics trades, last 26 weeks
What else happened in C4 Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Lynx1 Capital Management's other 5% stake reports
- Lynx1 Capital Management
5% stakeTScan Therapeutics
5% stakeTScan Therapeutics
TCRX
13.1% stake
20,519,148 sh
13.1% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeStoke Therapeutics
5% stakeStoke Therapeutics
STOK
6.5% stake
4,038,404 sh
6.5% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeiBio
5% stakeiBio
IBIO
5.4% stake
2,807,016 sh
5.4% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeGH Research
5% stakeGH Research
GHRS
19.3% stake
13,263,288 sh
19.3% stake
Filed 08/14
- Lynx1 Capital Management
5% stakePrecision Biosciences
5% stakePrecision Biosciences
DTIL
5.4% stake
1,390,611 sh
5.4% stake
Filed 07/20
